相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?
Rob W. van der Pluijm et al.
TRENDS IN PARASITOLOGY (2021)
Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review
Nadine K. Kayiba et al.
LANCET INFECTIOUS DISEASES (2021)
N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-gamma induced PD-L1 expression
Samir Mehndiratta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
RTS,S/AS01 vaccine (Mosquirix?): an overview
Matthew B. Laurens
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Design and optimization of orally spleen tyrosine kinase (SYK) inhibitors for treatment of solid tumor
Cheng Wang et al.
BIOORGANIC CHEMISTRY (2020)
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
Rob W. van der Pluijm et al.
LANCET (2020)
Malaria vaccines since 2000: progress, priorities, products
Patrick E. Duffy et al.
NPJ VACCINES (2020)
Emergence and clonal expansion of in vitro artemisinin-resistantPlasmodium falciparum kelch13R561H mutant parasites in Rwanda
Aline Uwimana et al.
NATURE MEDICINE (2020)
The antimalarial resistome - finding new drug targets and their modes of action
Krypton Carolino et al.
CURRENT OPINION IN MICROBIOLOGY (2020)
Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery
James M. Murithi et al.
CELL CHEMICAL BIOLOGY (2020)
Challenges and strategies for developing efficacious and long-lasting malaria vaccines
James G. Beeson et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Covalent Inhibition of the Histamine H3 Receptor
Gabor Wagner et al.
MOLECULES (2019)
Visible-Light-Mediated Nitration of Protected Anilines
Simon J. S. Duesel et al.
JOURNAL OF ORGANIC CHEMISTRY (2018)
Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase
Abdullah Akbar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Is the Mitochondrion a Good Malaria Drug Target?
Christopher D. Goodman et al.
TRENDS IN PARASITOLOGY (2017)
Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways
Erik L. Allman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Carboxyl radical-assisted 1,5-aryl migration through Smiles rearrangement
Asik Hossian et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
A broad analysis of resistance development in the malaria parasite
Victoria C. Corey et al.
NATURE COMMUNICATIONS (2016)
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond
Wesley C. Van Voorhis et al.
PLOS PATHOGENS (2016)
Malaria medicines: a glass half full?
Timothy N. C. Wells et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
An integrated flow and microwave approach to a broad spectrum protein kinase inhibitor
Cecilia Russell et al.
RSC ADVANCES (2015)
The role of ligand efficiency metrics in drug discovery
Andrew L. Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Synthesis of DIBAC analogues with excellent SPAAC rate constants
Marjoke F. Debets et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
Global Phenotypic Screening for Antimalarials
W. Armand Guiguemde et al.
CHEMISTRY & BIOLOGY (2012)
Mild, Simple, and Efficient Method for N-Formylation of Secondary Amines via Reimer-Tiemann Reaction
Lokesh A. Shastri et al.
SYNTHETIC COMMUNICATIONS (2011)
A novel design of artificial membrane for improving the PAMPA model
Xiaoxi Chen et al.
PHARMACEUTICAL RESEARCH (2008)
Novel potent neuropeptide YY5 receptor antagonists: Synthesis and structure-activity relationships of phenylpiperazine derivatives
Toshiyuki Takahashi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor
TI Richardson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H3 receptor antagonists
F Zaragoza et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)